MTD Mettler Toledo

Q1 2025 10-Q

Filed: May 2, 2025Period ending Mar 31, 2025

Health Care

Laboratory Analytical InstrumentsSEC EDGAR

Mettler Toledo (MTD) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 2, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• New risk: Negative gross margin impact expected from escalation in global trade disputes/tariffs in 2025, mitigated by ongoing company actions
• Updated operational risk: Recovery of prior-year shipping delays reduced current quarter sales growth by up to 12% in key regions, impacting near-term revenue

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$884M

Net Income

$164M

Net Margin

18.5%

Source: XBRL data from Mettler Toledo Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Mettler Toledo Quarterly Reports

Q3 2025 10-Q

Q2 2025 10-Q

Get deeper insights on Mettler Toledo

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.